Basophils increase in Crohn disease and ulcerative colitis and favor mesenteric lymph node memory TH17/TH1 response - 02/10/14
Doi : 10.1016/j.jaci.2014.05.025
Laurence Chapuy, MD a, Marwa Bsat, MSc a, Heena Mehta, PhD a, Manuel Rubio, BSc a, Keiko Wakahara, MD, PhD b, Vu Quang Van, PhD a, Nobuyasu Baba, PhD c, Cheolho Cheong, PhD d, Tae Jin Yun, MSc d, Benoît Panzini, MD e, Ramses Wassef, MD f, Carole Richard, MD f, Raja Tamaz, MD e, Geneviève Soucy, MD g, Guy Delespesse, MD, PhD h, Marika Sarfati, MD, PhD a 
a Immunoregulation Laboratory, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada
h Allergy Laboratory, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada
b Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan
c Center for Innovative and Translational Medicine, Kochi University Medical School, Kochi, Japan
d Cellular Physiology and Immunology Research Unit, Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada
e Department of Gastroenterology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada
f Department of Digestive Tract Surgery, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada
g Department of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada
| This work was supported by the Canadian Institutes for Health Research (grant no. CIHR:130533) and the Crohn's and Colitis Foundation of Canada. |
|
| Disclosure of potential conflict of interest: M. Bsat has received research support from Université de Montréal, Canada. V. Q. Van, C. Cheong, and Y. T. Jin have received research support from Canadian Institutes of Health Research (CIHR; grant no. 125933). G. Soucy is employed by the University of Montreal Medical Center (Centre Hospitalier de l’Université de Montréal). M. Sarfati has received research support from the CIHR (grant no. 130533) and is a faculty member of the University of Montreal. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 134 - N° 4
P. 978 - octobre 2014 Retour au numéro
Article précédent
- TNF-?/IL-17 synergy inhibits IL-13 bioactivity via IL-13R?2 induction
- Vahe Badalyan, Robert Thompson, Kezia Addo, Lee A. Borthwick, Andrew J. Fisher, Tatiana Ort, Timothy G. Myers, Thomas A. Wynn, Thirumalai R. Ramalingam
- Induction of remission of idiopathic anaphylaxis with rituximab
- Arturo Borzutzky, Pamela S. Morales, Verónica Mezzano, Sofía Nussbaum, A. Wesley Burks
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?